TABLE 2.
Prevalence of Obstructive CAD
| Prevalence |
||||||
| Obstructive disease | Overall multicenter, n = 1,160 | Center 1, n = 362 | Center 2, n = 191 | Center 3, n = 275 | Center 4, n = 332 | P |
| No disease | 442 (38.1) | 139 (38.4) | 72 (37.8) | 96 (34.9) | 135 (40.7) | 0.54 |
| One-vessel disease | 321 (27.7) | 100 (27.6) | 62 (32.5) | 79 (28.7) | 80 (24.1) | 0.22 |
| Double-vessel disease | 240 (20.7) | 74 (20.4) | 33 (17.3) | 64 (23.3) | 69 (20.8) | 0.48 |
| Triple-vessel disease | 157 (13.5) | 49 (13.6) | 24 (11.0) | 36 (13.1) | 48 (14.5) | 0.93 |
| Per-patient | 718 (61.9) | 223 (61.6) | 119 (62.3) | 179 (65.1) | 197 (59.3) | 0.54 |
| LAD | 509 (43.9) | 163 (45.0) | 84 (44.0) | 124 (45.1) | 138 (41.6) | 0.78 |
| LCx | 384 (33.1) | 121 (33.4) | 60 (31.4) | 92 (33.5) | 111 (33.4) | 0.96 |
| RCA | 379 (32.7) | 111 (30.7) | 56 (29.3) | 99 (36) | 113 (34.0) | 0.35 |
| Per-vessel (LAD + LCx + RCA) | 1,272/3,480 (36.6) | 395/1,086 (36.4) | 200/573 (34.9) | 315/825 (38.2) | 362/996 (36.4) | 0.65 |
Data are numbers followed by percentages in parentheses.